(Q44007004)

28 November 2017

title

Long-term treatment with sodium warfarin results in decreased femoral bone strength and cancellous bone volume in rats (English)

1 reference

28 November 2017

1 reference

Ryan R Simon

1

1 reference

28 November 2017

Suzanne M Beaudin

2

1 reference

28 November 2017

Marilyn Johnston

3

1 reference

28 November 2017

Kimberly J Walton

4

1 reference

28 November 2017

Stephen G Shaughnessy

5

1 reference

28 November 2017

language of work or name

1 reference

1 February 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

105

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

353-358

1 reference

Warfarin therapy: a review of the literature since the Fifth American College of Chest Physicians' Consensus Conference on Antithrombotic Therapy

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Oral anticoagulant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Hemorrhagic complications of long-term anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Warfarin necrosis of the skin and subcutaneous tissue of the male external genitalia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Maternal and fetal sequelae of anticoagulation during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Reduced axial bone mineral content in patients taking an oral anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Decreased peripheral bone mineral content in patients under anticoagulant therapy with phenprocoumon

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Heparins, coumarin, and bone density

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Long-term Oral Anticoagulation Reduces Bone Mass in Patients with Previous Hemispheric Infarction and Nonrheumatic Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Long-term use of oral anticoagulants and the risk of fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Normal cortical bone mass in patients after long term coumadin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Vitamin K and maintenance of skeletal integrity in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Bone strength: the bottom line

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Dexamethasone effects on mechanical, geometric and densitometric properties of rat femur diaphyses as described by peripheral quantitative computerized tomography and bending tests.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Growth hormone is not able to counteract osteopenia of rat cortical bone induced by glucocorticoid with protracted effect.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Skeletal functions of vitamin K-dependent proteins: not just for clotting anymore.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Increased bone formation in osteocalcin-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Excessive mineralization with growth plate closure in rats on chronic warfarin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Vitamin K-induced changes in markers for osteoblast activity and urinary calcium loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900035-X

7 January 2021

10.1016/S0049-3848(02)00035-X

Identifiers

DOI

1 reference

28 November 2017

1 reference